临床用血短缺成常态 自体输血或纳入医院考核

2018-01-14 张伟东、关飞舜、梁明月 中国卫生质量杂志

自体输血是利用患者自身血液或血液成分,以满足手术或紧急情况时需要的一种输血疗法。目前常用方法主要有贮存式自体输血、稀释式自体输血和回收式自体输血。合理应用自体输血技术,可以有效节约血液资源,减少同种异体输血,避免输血传染疾病发生[1]。在当前血液采集量增长无法满足临床用血需求增长的情况下,本研究对广州血液中心供血辖区内医院发放调查问卷,旨在了解广州地区医院自体输血开展情况,探讨如何推动各级医院

自体输血是利用患者自身血液或血液成分,以满足手术或紧急情况时需要的一种输血疗法。目前常用方法主要有贮存式自体输血、稀释式自体输血和回收式自体输血。合理应用自体输血技术,可以有效节约血液资源,减少同种异体输血,避免输血传染疾病发生[1]。在当前血液采集量增长无法满足临床用血需求增长的情况下,本研究对广州血液中心供血辖区内医院发放调查问卷,旨在了解广州地区医院自体输血开展情况,探讨如何推动各级医院提升自体输血开展率和应用率。

1材料与方法

1.1调查对象

按照《医疗机构临床血管理办法》第二十二条要求,结合本地区临床用血情况,选取供血辖区内三级医院、二级医院、妇幼保健院以及2015年红细胞用量达到500U的医院共90家进行问卷调查。血液用量数据来自广州血液中心采供血信息系统数据库,90家医院2015年红细胞用量占该中心2015年红细胞总供应量的91% 。共发出90份调查表,收回67份,回收率为74.44%,23家医院因院规要求数据资料不允许外泄未收回调查问卷。

1.2调查内容

根据《广州市卫生局关于加强我市医疗机构临床用血管理工作的通知》要求设计调查问卷,在2016年定期督导检查工作时进行数据核对。

调查内容包括医院性质、自体输血开展情况和自体输血应用情况。(1)自体输血开展情况。临床有1例以上患者应用贮存式或稀释式或回收式自体输血技术回输血液,判断该院已开展自体输血。同时,对未开展自体输血医院进行原因调查,选项(可多选)有:①医院输血患者较少,对自体输血技术未深入了解;(2)人员紧张,技术力量薄弱;(3)医院床位紧张,床位周转周期不足;(4)自体输血操作繁杂,输异体血液相对简单方便;(5)血液中心供应血液已满足用血需求;(6)自体输血技术收费项目未纳入医保报销体系;(7)收费标准低,无法收回医疗成本;(8)其他。自体输血开展率=已开展任一形式自体输血技术的医院数÷收回调查表医院数×100%。(2)自体输血应用情况。按科室分类统计各院2015年围术期输血患者例数和开展贮存式自体输血、稀释式自体输血、回收式自体输血例数。自体输血应用率(%)=单位范围内回输自体血液的围术期患者例数÷单位范围内(回输自体血液+异体输血)的围术期患者例数×100%。

1.3数据处理

采用Excel表格对数据进行汇总,利用SPSS 16.0统计软件进行分析。

2结果

67医院中,三级医院35家,二级医院27家,一级医院5家;综合医院47家,专科医院20家(其中妇儿专科医院12家,骨伤专科医院3家,脑专科医院1家,手外专科医院3家,传染病专科1家)。

其中,开展自体输血医院30家,医院自体输血开展率为44.78%,三级医院有29家已开展自体输血(82.86%),二级医院有1家已开展自体输血(3.7%)。三级医院与二级医院自体输血开展率比较有统计学差异(P<0.001)。

未开展自体输血的37家医院中,包括1家三级医院、26家二级医院和5家一级医院。未开展原因从高到低排序依次为:医院输血患者较少,对自体输血技术未深入了解(62.16%)>人员紧张,技术力量薄弱(59.46%)>血液中心供应血液已满足用血需求(27.03%)>医院床位紧张,床位周转周期不足(10.81%)>自体输血操作繁杂,输异体血液相对简单方便(8.11%)>自体输血技术收费项目未纳入医保报销体系(5.41%)=收费标准太低,无法收回医疗成本(5.41%)。

30家已开展自体输血的医院中,2015年整体贮存式自体输血应用率为0.5%,稀释式自体输血应用率为2.7%,回收式自体输血应用率为15.4%。不同科室自体输血应用率分别为心血管外科63.8%、骨科28.7%、移植外科12.9%、颅脑外科11.4%、产科2.3%、妇科1.0%。心血管外科回收式自体输血应用率为48.6%,显着高于骨科和颅脑外科;心血管外科稀释式自体输血应用率为15.1%,显着高于骨科和移植外科。

3讨论

近年来,临床血液用量短缺现象已成为常态。有文献[2-3]表明,开展自体输血是减少异体输血用量的有效措施。本研究显示广州市医疗机构自体输血开展率为44.78%,显着高于文献报道的4.11%[4]和8.6%[5],表明自体输血作为一种血液保护措施在广州已得到较多医院的认同。但与国外发达国家的自体输血开展率相比尚存在一定差距。未开展自体输血的37家医院中,二级及以下医院对自体输血知晓度和认同度较弱,技术力量薄弱,因手术量和就诊疾病种类原因,对血液需求用量较少,普遍缺乏主动解决血液短缺的急迫感和动力。对此,建议卫生行政部门加大自体输血宣传力度,提倡和督促二级及以下医院主动谋求三级医院的技术支持,同时将自体输血开展纳入医院考核范围,设定为临床用血督导检查内容之一。

调查显示,贮存式自体输血应用率极低,仅0.5%。国外文献[6]报道称,贮存式自体输血应用呈逐年下降趋势,下降原因是采集后血液浪费较为严重。但本调查显示,在广州地区贮存式自体输血开展较低的原因并非如此,而是三级医院床位紧张,传统贮存式自体输血采血方案耗时较长(约需3周~5周),该项技术的广泛应用会加剧医院床位不足的矛盾。有文献报道[7] 称,优化的贮存式自体输血采血方案仅需要1天~7天。因此,建议在三级医院对适宜人群可采用优化采血方案或自体血与异体血互补的采血模式(仅在手术72h前采集200ml~400ml血液),以缩短择期手术术前备血时间;在二级及以下医院因对床位周转周期考虑较宽松,可维持传统采血方案。《临床输血技术规范》第七条规定贮血式自体输血是由输血科(血库)负责采血和贮血,经治医师负责输血过程的医疗监护。由于该项技术的设备要求仅为贮血冰箱,是有输血条件的基层医院必备设备之一,因此,贮存式自体输血技术是二级和一级医院最容易开展的自体输血技术。建议设立定点三级医院对基层医院进行规范化培训,制定适当的奖惩措施,提高医务人员积极性,促使贮存式自体输血技术广泛开展。

国外文献[8]报道称,自体输血主要应用于心脏手术(50%)和骨科手术(45%)。本次调查显示,本地区自体输血主要应用于心脏手术(63.8%)和骨科手术(28.7%)。由此可见,心血管外科领域相较于骨科和其他学科,自体输血更得到重视。心血管外科自体输血应用方式以回收式自体输血为主(48.6%),稀释式自体输血次之(15.1%),贮存式自体输血较少(0.1%),说明回收式自体输血技术是一项成熟的输血方法。建议医院可将培训自体血液回收人员和购置血液回收设备设定为开展心脏外科手术的必备条件之一,从而减轻异体血液供应不足的压力。骨科、颅脑外科、妇科、产科自体输血应用率均低于国内文献[9-10]报道,建议开展自体输血的综合医院着重在这4个学科领域推动自体输血应用,加强城市家医院的横向交流,从而提升本地区整体自体输血发展水平。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1754376, encodeId=6c3d1e543761f, content=<a href='/topic/show?id=490f3558e05' target=_blank style='color:#2F92EE;'>#医院考核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35587, encryptionId=490f3558e05, topicName=医院考核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fe136667711, createdName=rgjl, createdTime=Sat Oct 20 10:37:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259682, encodeId=8132125968272, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628111, encodeId=51fc162811174, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278520, encodeId=5f982e85205d, content=不错的文章.值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Jan 14 21:44:25 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278515, encodeId=90be2e85151d, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sun Jan 14 21:23:01 CST 2018, time=2018-01-14, status=1, ipAttribution=)]
    2018-10-20 rgjl
  2. [GetPortalCommentsPageByObjectIdResponse(id=1754376, encodeId=6c3d1e543761f, content=<a href='/topic/show?id=490f3558e05' target=_blank style='color:#2F92EE;'>#医院考核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35587, encryptionId=490f3558e05, topicName=医院考核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fe136667711, createdName=rgjl, createdTime=Sat Oct 20 10:37:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259682, encodeId=8132125968272, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628111, encodeId=51fc162811174, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278520, encodeId=5f982e85205d, content=不错的文章.值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Jan 14 21:44:25 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278515, encodeId=90be2e85151d, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sun Jan 14 21:23:01 CST 2018, time=2018-01-14, status=1, ipAttribution=)]
    2018-01-16 windight
  3. [GetPortalCommentsPageByObjectIdResponse(id=1754376, encodeId=6c3d1e543761f, content=<a href='/topic/show?id=490f3558e05' target=_blank style='color:#2F92EE;'>#医院考核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35587, encryptionId=490f3558e05, topicName=医院考核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fe136667711, createdName=rgjl, createdTime=Sat Oct 20 10:37:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259682, encodeId=8132125968272, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628111, encodeId=51fc162811174, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278520, encodeId=5f982e85205d, content=不错的文章.值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Jan 14 21:44:25 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278515, encodeId=90be2e85151d, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sun Jan 14 21:23:01 CST 2018, time=2018-01-14, status=1, ipAttribution=)]
    2018-01-16 liuxiaona
  4. [GetPortalCommentsPageByObjectIdResponse(id=1754376, encodeId=6c3d1e543761f, content=<a href='/topic/show?id=490f3558e05' target=_blank style='color:#2F92EE;'>#医院考核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35587, encryptionId=490f3558e05, topicName=医院考核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fe136667711, createdName=rgjl, createdTime=Sat Oct 20 10:37:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259682, encodeId=8132125968272, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628111, encodeId=51fc162811174, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278520, encodeId=5f982e85205d, content=不错的文章.值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Jan 14 21:44:25 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278515, encodeId=90be2e85151d, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sun Jan 14 21:23:01 CST 2018, time=2018-01-14, status=1, ipAttribution=)]
    2018-01-14 1e1b8538m79(暂无匿称)

    不错的文章.值得拥有

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1754376, encodeId=6c3d1e543761f, content=<a href='/topic/show?id=490f3558e05' target=_blank style='color:#2F92EE;'>#医院考核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35587, encryptionId=490f3558e05, topicName=医院考核)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fe136667711, createdName=rgjl, createdTime=Sat Oct 20 10:37:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259682, encodeId=8132125968272, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1628111, encodeId=51fc162811174, content=<a href='/topic/show?id=b19de323897' target=_blank style='color:#2F92EE;'>#短缺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73238, encryptionId=b19de323897, topicName=短缺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=288421156589, createdName=liuxiaona, createdTime=Tue Jan 16 11:37:00 CST 2018, time=2018-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278520, encodeId=5f982e85205d, content=不错的文章.值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun Jan 14 21:44:25 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278515, encodeId=90be2e85151d, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sun Jan 14 21:23:01 CST 2018, time=2018-01-14, status=1, ipAttribution=)]
    2018-01-14 戒馋,懒,贪

    谢谢分享学习了

    0